Guerbet S. A. Total Liabilities
Guerbet S. A. total liabilities. Based on the latest financial reports, Guerbet S. A. (GBT) has total liabilities worth €669.94 Million EUR (≈ $783.23 Million USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check Guerbet S. A. (GBT) asset resilience to evaluate the company's liquid asset resilience ratio.
Total Liabilities of Guerbet S. A. (2004–2025)
Total liabilities of Guerbet S. A. from 2004 to 2025. This chart illustrates how Guerbet S. A.'s total liabilities have evolved over time, based on quarterly financial data. Explore GBT long-term investments to assets to see how much of total assets are deployed in long-term investments.
Guerbet S. A. Competitors by Total Liabilities
The table below lists competitors of Guerbet S. A. ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
NextEye Co. Ltd
KQ:137940
|
Korea | ₩40.27 Billion |
|
United Recommend International Co Ltd
TWO:5321
|
Taiwan | NT$4.17 Billion |
|
Papoutsanis S.A
AT:PAP
|
Greece | €47.64 Million |
|
Shinsegae Food
KO:031440
|
Korea | ₩445.57 Billion |
|
Jung Shing Wire Co Ltd
TW:1617
|
Taiwan | NT$1.14 Billion |
|
Phoenix Group Holdings PLC
LSE:PHNX
|
UK | GBX331.44 Billion |
|
Cemacon Zalau
RO:CEON
|
Romania | RON176.26 Million |
|
Negri Sembilan Oil Palms Bhd
KLSE:2038
|
Malaysia | RM87.98 Million |
Liability Composition Analysis (2004–2025)
This chart breaks down Guerbet S. A.'s total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see GBT asset base.
Liquidity & Leverage Metrics
Guerbet S. A. Total Liabilities Ratios Explained
Guerbet S. A. total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 2.49 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 2.51 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.72 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Guerbet S. A.'s debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Guerbet S. A. (2004–2025)
The table below shows the annual total liabilities of Guerbet S. A. from 2004 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | €669.94 Million ≈ $783.23 Million |
+3.76% |
| 2024-12-31 | €645.68 Million ≈ $754.87 Million |
-0.20% |
| 2023-12-31 | €646.97 Million ≈ $756.38 Million |
+15.52% |
| 2022-12-31 | €560.07 Million ≈ $654.78 Million |
-5.99% |
| 2021-12-31 | €595.74 Million ≈ $696.48 Million |
+3.08% |
| 2020-12-31 | €577.95 Million ≈ $675.69 Million |
-6.73% |
| 2019-12-31 | €619.68 Million ≈ $724.47 Million |
-13.22% |
| 2018-12-31 | €714.05 Million ≈ $834.80 Million |
+16.78% |
| 2017-12-31 | €611.45 Million ≈ $714.85 Million |
-14.28% |
| 2016-12-31 | €713.35 Million ≈ $833.98 Million |
+15.05% |
| 2015-12-31 | €620.06 Million ≈ $724.91 Million |
+186.36% |
| 2014-12-31 | €216.53 Million ≈ $253.15 Million |
-2.15% |
| 2013-12-31 | €221.29 Million ≈ $258.72 Million |
-5.73% |
| 2012-12-31 | €234.76 Million ≈ $274.46 Million |
-0.07% |
| 2011-12-31 | €234.92 Million ≈ $274.65 Million |
+11.08% |
| 2010-12-31 | €211.49 Million ≈ $247.26 Million |
+11.89% |
| 2009-12-31 | €189.01 Million ≈ $220.98 Million |
-4.17% |
| 2008-12-31 | €197.23 Million ≈ $230.58 Million |
+5.89% |
| 2007-12-31 | €186.26 Million ≈ $217.75 Million |
+6.81% |
| 2006-12-31 | €174.37 Million ≈ $203.86 Million |
+12.75% |
| 2005-12-31 | €154.65 Million ≈ $180.81 Million |
+14.17% |
| 2004-12-31 | €135.46 Million ≈ $158.37 Million |
-- |
About Guerbet S. A.
Guerbet SA provides a range of contrast media, medical devices, and digital and AI solutions for diagnostic and interventional imaging worldwide. It offers DOTAREM, a macrocyclic gadolinium-based contrast agent for use in contrast-enhanced MRI examinations; Elucirem, a macrocyclic gadolinium-based contrast agent for use in contrast-enhanced resonance imaging; UNIK, a diagnostic imaging interconne… Read more